Abstract
Phenytoin (DPH) is a widely used anticonvulsant drug but a conclusive mode of action is not yet clear. This study was undertaken to assess the effects of chronic administration of DPH on monoamine levels. DPH (50 mg/kg body weight) was administered to adult male Wistar rats by intraperitoneal injections for 45 days and the regional brain levels of norepinephrine (NE), dopamine (DA) and serotonin (5-HT) were assayed using high performance liquid chromatographic (HPLC) method. The experimental rats revealed no behavioral deficits of any kind nor body and brain weight deficits were observed. Increased NE levels were observed after DPH administration in motor cortex (P<0.05), striatum-accumbens (P<0.01) and hippocampus (P<0.01), whereas, NE level was decreased in brain stem (P<0.05). DA levels were increased in striatum-accumbens (P<0.05), hypothalamus (P<0.001) and cerebellum (P<0.001) but decreased in brainstem (P<0.01). In DPH treated rats, 5-HT levels were increased in motor cortex (P<0.001) but decreased in cerebellum (P<0.001) when compared to control group of rats. The present study suggest that chronic administration of DPH induces alterations in monoamine levels in specific brain regions. DPH seems to mediate, its anticonvulsant action by selectively altering the monoamine levels in different brain regions.
Similar content being viewed by others
References
Perry, J. G., McKinney, L., and Dewier, P. 1978. The cellular mode of action of the antiepileptic drug 5,5 diphenylhydantoin. Nature (Lond.) 272:271–273.
DeLorenzo, R. J., and Glaser, G. H. 1976. Effect of diphenyl hydantoin on the endogenous phosphorylation of brain protein. Brain Res. 105:381–386.
Yaari, Y., Selzer, M. E., and Pincus, J. H. 1986. Phenytoin: Mechanisms of its anticonvulsant action. Ann. Neurol. 20:171–184.
Lewin, E., and Bleck, V. 1971. The effect of diphenylhydantoin administration on cortex potassium—activated phosphatase. Neurology 21:417–418.
De Weer, P. 1980. Phenytoin blockage of resting sodium channels. Adv. Neurol. 27:253–261.
Ondrusek, M. G., Belknap, J. K., and Leslie, S. W. 1979. Effects of acute and chronic barbiturate administration on synaptosomal calcium accumulation. Mol. Pharmacol. 15:386–395.
Brouillette, W. J., Brown, G. B., Delorey, T. M., and Liang, G. 1990. Sodium channel binding and anticonvulsant activities of hydantoins containing conformationally constrained 5-phenyl substituents. J. Pharmacol. Sci. 79:871–874.
Woodbury, D. M. 1982. Phenytoin: mechanism of action. Pages 269–282,in Woodbury, D. M., Penry, J. K. and Pippenger C. E. (eds.), Antiepileptic drugs second edition, Raven Press, New York.
Ito, S., Nakazato, Y., and Ohga, A. 1978. Pharmacological evidence for the involvement of Na+ channels in the release of catocholamines from perfused adrenal glands. Brit. J. Pharmacol. 62:359–361.
Kilpatrick, D. L., Slepetis, R., and Kirshner, N. 1981. Ion channels and membrane potential in stimulus secretion coupling in adrenal medulla cells. J. Neurochem. 36:1245–1255.
Jones, G. L., and Woodbury, D. M. 1985. Biochemistry of antiepileptic drugs. Pages 254–268.in Frey H. H. and Janz D. (eds) Handbook of experimental pharmacology. Vol. 74, Springer-Verlag, Berlin.
Reynolds, E. H. 1983. Mental effects of antiepileptic medication. A review. Epilepsia 24 (Suppl. 2):85–95.
Quattrone, A., Crunelli, V., and Samanin, R. 1978. Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selective depletions of brain monoamines. Neuropharmacol. 17:643–647.
Waldmeier, P. C., Baumann, P. A., Fehr, B., De Herdt, P., and Maitre, L. 1984. Carbamazepine decreases catecholamine turnover in the rat brain. J. Pharmacol. Exp. Ther. 231:166–172.
Devinsky, O., Emoto, S., Goldstein, D. S., Stull, R., Porter, R. J., Theoder, W. H., and Suzan Nadi, N. et al., 1992. Cerebrospinal fluid and serum levels of Dopa, catechols and monoamine metabolites in patients with epilepsy. Epilepsia 33:263–270.
Lindgren, S., Anden, N. E., and Anden, M. G. 1982. A Flourometric method for determination of GABA in tissue following cation exchange chromatography and condensation with Ophthalaldehyde. J. Neural Transm 55:243–252.
Meshkibaf, M. H., Subhash, M. N., Lakshmana, M. K., and Rama Rao, B. S. S. 1994. Sodium Valproate induced alteration in monoamine levels in different regions of the rat brain, Neurochemistry Int. 24:67–72.
Masuda, Y., Utsuim, Y., Shiraishi, Y., Karasava, T., Yoshida, K., and Shimizu, M. 1979. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfomoyl-methyl-1,2 benzisozaxole (AD-810), a new anticonvulsant agent and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia 20:623–633.
DeLorenzo, R. J. 1980. Phenytoin: Calcium and calmodulin dependent protein phosphorylation and neurotransmitter release. Pages 56–71,in Glaser, G. H., Penry, J. K. and Woodbury D. M. (eds.), Antiepileptic drugs: Mechanisms of action Raven Press, New York.
Pincus, J. H., and Weinfeld, H. M. 1984. Effect of phenytoin on3H norepinephrine release from synaptosomes. Brain Res. 348:387–390.
Boer, T. H., Stoof, J. C., and Duijn H. V. 1982. The effects of convulsant and anticonvulsant drugs on the release of radiolabeled GABA, glutamate, noradrenaline, serotonin and acetylcholine from rat cortical slices. Brain Res. 253:153–160.
Trottier, S., Berger, B., Chanvel, P., Dedek, J., and Gay, M. 1981. Alterations of the cortical noradrenergic systems in chronic cobalt epileptogenic foci in the rat: A histofluorescent and biochemical study. Neuroscience 6:1069–1080.
Remler, M. P., Sigvardt, K., and Marcussen, W. H. 1986. Pharmacological response of systematically derived focal epileptic lesions. Can. Med. Assoc. J. 74:365–366.
Jobe, P., Laird, H., Ko, K. H., Ray, T., and Dailey, J. W. et al. 1982. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy prone rats. Epilepsia 23:359–366.
Altamura, A. C., Bonati, M., Brunello, N., Giardano, P. L., and Algori, S. et al., 1978. The activity of some neurotransmitter synthesizing enzymes in experimental cobalt epilepsy. Neuroscience Lett. 7:83–87.
Elliott, P. N., Jenner, P., and Chadwick, O. 1977. The effect of diphenylhydantoin on central catecholamine containing neuronal systems. J. Pharm. Pharmacol., 29:41–43.
Quattrone, A., Annunziato, L., Aguglia, U., and Preziosi, P. 1981. Carbamazepine, phenytoin and phenobarbitone do not influence brain catecholamine uptake, invivo in male rats. Arch. Int. Pharmacodynam. Ther. 252:180–185.
Yanagihara, T., and Hamberger, A. 1971. Distribution of diphenyl-hydantoin in rat organs: Study with neuron, glia and subcellular fractions. J. Pharmacol. Exp. Ther. 179:611–618.
De Lima, T. C. M., and Palermo, Neto. J. 1980. The effects of diphenyl hydantoin on rat behaviour. Psychopharmacology (Berlin) 69:183–185.
Lalonde, R. 1985. Dopaminergic supersensitivity after long term administration of phenytoin in the rats. Epilepsia. 26:81–84.
Mori, A., Hiramatsu, M., and Namha, S. 1987. Decreased dopamine level in the epileptic focus. Res. Commun. Chem. Pathol. Pharmacol. 56:157–164.
Laird, H. 1983. Abnormal concentrations and turnover rates of norepinephrine and dopamine in brains of genetically seizure-susceptible rats. Epilepsia 24:107–113.
Bernardi, G., Chenubini, E., Marciani, M. G., and Mercuri, N. 1982. Responses of intracellular recorded cortical neurons to the iontophoretic application of dopamine. Brain Res. 245:267–274.
Stanzione, P., Galabresi, P., Mercuri, N. and Bernardi, G. 1984. Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation, an invitro study. Neuroscience 13:1105–1116.
Bonnycastle, D. D., Bonny, Castle, M. F., and Anderson, E. G. 1962. The effect of a number of central depressant drugs upon brain 5-hydroxytryptamine levels in the rat. J. Pharmacol. Exp. Ther. 196:469–475.
Chadwick, D., Jenner, P., and Reynolds, E. H. 1975 Amines, anticonvulsants and epilepsy. Lancet 1:473–476.
Azzaro, A. J., Gutrecht J. A., and Smith, D. J. 1973. Effect of diphenylhydantoin on the uptake and catabolism of L-(3H)-norepinephrine in vitro in rat cerebral cortex tissue. Biochem. Pharmacol. 22:2719–2724.
Fry, B. W., and Ciarlone, A. E. 1981. Effect of phenytoin on mouse cerebellar 5-hydroxy tryptamine and norepinephrine. Neuropharmacology 20:623–625.
Goldstein, D., Nadi, N. S., and Stull, R. 1988. Levels of catechols in normal and epileptic regions of the human brain. J. Neurochem. 50:225–229.
Schreiber, R. A., and Schlesinger, K. 1971. Circadian rhythms and seizure susceptibility: relation to serotonin and norepinephrine in brain. Physiol. Behav. 6:635–640.
Pintor, M., Pocotte, S., Mefford, I., and Indols, 1988. Catechol and tryosine hydroxylase in the human epileptic cortex. Soc. Neurosci. Abstr. 14:1032.
Mac Donald, J. W., Garofalo, E. A., Hood, J., Sackellares, J. C., Gilman, S., McKeever, P. E., Troncoso, J. C., and Johnston, M. V. 1991. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29:529–541.
Cavalheiro, E. A., Fernandes, M. J., Turski, L., and Naffah-Mazzacoratti, M. G. 1994. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 35:1–11.
Green J. R., Halpern, L. M., Thomas, Jr. E. D., and Amick-Corkill, J. A. 1978. The effect of diphenylhydantoin on the activity of selected enzymes in chronic isolated cerebral cortex of rat. Epilepsia 14:223–232.
Meshki Baf, M. H., Subhash, M. N., Lakshmana, M. K., and Sridhara Rama Rao, B. S. 1994. Alterations in monoamine levels in discrete regions of rat brain after chronic administration carbamazepine. Neurochem. Res. 19:1137–1141.
Meshki Baf, M. H., Subhash, M. M., Lakshmana, M. K., and Sridhara Rama Rao, B. S. 1994. Alterations in brain regional monoamine levels after chronic administration of phenobarbitone to adult rats. Biogenic Amines 10:213–219.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meshkibaf, M.H., Subhash, M.N., Lakshmana, K.M. et al. Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochem Res 20, 773–778 (1995). https://doi.org/10.1007/BF00969688
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969688